Yue-Zhong Hou

Generation and evaluation of 3D digital casts of maxillary defects based on multisource data registration: A pilot clinical study

Qijun Ma, Yongsheng Zhou, H. Ye, 2017, The Journal of prosthetic dentistry.

Profiles of NK cell subsets are associated with successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia and changes following interferon treatment

Ya-Zhen Qin, Hao Jiang, Xiao-jun Huang, 2021, Annals of Hematology.

Novel BCR-ABL1 Tyrosine Kinase Inhibitor (TKI) HQP1351 (Olverembatinib) Is Efficacious and Well Tolerated in Patients with T315I-Mutated Chronic Myeloid Leukemia (CML): Results of Pivotal (Phase II) Trials

Dajun Yang, Q. Jiang, Y. Zhai, 2020 .

An Updated Safety and Efficacy Results of Phase 1 Study of HQP1351, a Novel 3rd Generation of BCR-ABL Tyrosine Kinase Inhibitor (TKI), in Patients with TKI Resistant Chronic Myeloid Leukemia

Dajun Yang, Q. Jiang, Xiao-jun Huang, 2019, Blood.

Inflatable hollow obturator prostheses for patients undergoing an extensive maxillectomy: a case report

H. Ye, Yong-sheng Zhou, Yue-Zhong Hou, 2012, International Journal of Oral Science.

[Analysis of the efficacy and influencing factors of nilotinib or dasatinib as second- or third-line treatment in patients with chronic myeloid leukemia in the chronic phase and accelerated phase].

Q. Jiang, T. Yuan, Y. Lai, 2020, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.